Interferon alpha-2b has been used in the treatment of COVID-19 in China and Cuba and is a part of treatment guidelines of the Chinese government AHMEDABAD : Pharma major Zydus Cadila said on Monday its biological therapy Pegylated Interferon alpha-2b can emerge as one of the pathways to treat COVID-19.
The treatment has emerged after the publication of two non-peer reviewed research articles at bioRxiv and medRxiv, the COVID-19 pre-print servers hosted by Cold Spring Harbor Laboratory.
The first one by the University of Texas Medical Branch in Galveston showed evidence of a direct anti-viral effect of Interferon alpha against novel coronavirus in vitro.